Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00000751
Status:
COMPLETED
Last Update Posted:
2008-09-30
First Post:
1999-11-02
Brief Title:
A Phase III Randomized Double-Blind Controlled Study of the Use of Anti-HIV Immune Serum Globulin HIVIG for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine AZT
Sponsor:
Organization:
National Institute of Allergy and Infectious Diseases NIAID